Three things to know about the US government’s new strategy for standards development
Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP
Here’s the critical background to know as innovators today participate in a USPTO listening session about the intersection between standards development and IP
A preliminary injunction strikes a heavy blow against NanoString Technologies which already withdrew from Germany due to a previous 10x injunction and now must do so from 16 more European countries
In the second part of IAM’s exclusive interview with USPTO Director Kathi Vidal, she shares her thoughts on international patent issues
23 February 2023
23 February 2023
Joerg Thomaier also shares his thoughts on the UPC and EPO patent quality in an exclusive IAM interview
22 February 2023
Saturday Opinion: SCOTUS enablement review has exposed divisions among innovative life sciences companies
18 February 2023
Triveni Interchem and its director deliberately flouted sales ban, rules Delhi judge
14 February 2023
The Senate Judicial Committee has advanced several IP bills targeting life sciences rights owners
13 February 2023
As bioinformatics and computational genomics companies push the boundaries of technology, it is important they overcome subject matter eligibility challenges to protect their innovations
08 February 2023
But patentee worried further action could ‘exhaust’ it as MedTech company moves to appeal
07 February 2023
GW’s recent ANDA lawsuit is a landmark moment, but will remain untypical of cannabis IP litigation
06 February 2023
The Dusselfdorf Regional Court has issued a sales ban against eight generics in the much-watched dispute
03 February 2023
Unlock unlimited access to all IAM content